XML 42 R26.htm IDEA: XBRL DOCUMENT v3.25.0.1
EARNINGS PER COMMON SHARE
 12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
EARNINGS PER COMMON SHARE EARNINGS PER COMMON SHARE
Potentially issuable shares of common stock include shares issuable upon the exercise of outstanding employee stock option awards, common stock issuable under the Company’s ESPP, unvested RSUs and contingent issuances of common stock related to the Company's convertible debt.
The following table sets forth the computation of basic and diluted earnings per common share (common shares in thousands):
Twelve Months Ended
December 31,
202420232022
Numerator:
Net income, basic
$426,859 $167,645 $141,561 
Add: Interest expense, net of tax, on the Company's convertible debt
7,327 — — 
Net income, diluted
$434,186 $167,645 $141,561 
Denominator:
Weighted-average common shares outstanding, basic190,027 187,834 185,266 
Effect of dilutive securities:
Common stock issuable under the Company's equity incentive plans2,316 3,761 3,697 
Common stock issuable under the Company’s convertible debt (1)
4,365 — — 
Weighted-average common shares outstanding, diluted196,708 191,595 188,963 
Earnings per common share, basic
$2.25 $0.89 $0.76 
Earnings per common share, diluted
$2.21 $0.87 $0.75 
In addition to the equity instruments included in the table above, the table below presents potential shares of common stock that were excluded from the computation of diluted earnings per common share as they were anti-dilutive (in thousands):
Twelve Months Ended
December 31,
202420232022
Common stock issuable under the Company's equity incentive plans
9,438 8,072 8,148 
Common stock issuable under the Company’s convertible debt (1)
— 8,335 8,335 
Total number of potentially issuable shares9,438 16,407 16,483 
(1)    If converted, the Company would issue 4.0 million shares under the 2024 Notes and 4.4 million shares under the 2027 Notes. The Company’s 2024 Notes matured in August 2024 and substantially all holders were repaid in cash. For additional discussion of our convertible debt, see Note 10 to these Consolidated Financial Statements.